119 related articles for article (PubMed ID: 9233039)
21. Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma.
Floeth FW; Shand N; Bojar H; Prisack HB; Felsberg J; Neuen-Jacob E; Aulich A; Burger KJ; Bock WJ; Weber F
Cancer Gene Ther; 2001 Nov; 8(11):843-51. PubMed ID: 11773974
[TBL] [Abstract][Full Text] [Related]
22. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of malignant brain tumor].
Kubo O; Takakura K
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1583-92. PubMed ID: 8060132
[TBL] [Abstract][Full Text] [Related]
24. [Controversy on treatments for gliomas].
Nomura K
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1650-6. PubMed ID: 9757188
[TBL] [Abstract][Full Text] [Related]
25. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
26. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
27. [Gene therapy for malignant brain tumors--the present conditions and the prospects].
Nakahara N; Yoshida J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():499-503. PubMed ID: 16201571
[No Abstract] [Full Text] [Related]
28. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
29. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene.
Kim JH; Kim SH; Brown SL; Freytag SO
Cancer Res; 1994 Dec; 54(23):6053-6. PubMed ID: 7954444
[TBL] [Abstract][Full Text] [Related]
30. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
31. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites.
Li S; Gao Y; Tokuyama T; Yamamoto J; Yokota N; Yamamoto S; Terakawa S; Kitagawa M; Namba H
Cancer Lett; 2007 Jun; 251(2):220-7. PubMed ID: 17196326
[TBL] [Abstract][Full Text] [Related]
32. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
33. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
34. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
35. Radiation-inducible caspase-8 gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):517-25. PubMed ID: 18407431
[TBL] [Abstract][Full Text] [Related]
36. [Biology and gene therapy of glioma].
Sanson M; Hoang-Xuan K
Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353
[TBL] [Abstract][Full Text] [Related]
37. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.
Immonen A; Vapalahti M; Tyynelä K; Hurskainen H; Sandmair A; Vanninen R; Langford G; Murray N; Ylä-Herttuala S
Mol Ther; 2004 Nov; 10(5):967-72. PubMed ID: 15509514
[TBL] [Abstract][Full Text] [Related]
38. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
Hoshi M; Harada A; Kawase T; Uyemura K; Yazaki T
Cancer Gene Ther; 2000 May; 7(5):799-805. PubMed ID: 10830727
[TBL] [Abstract][Full Text] [Related]
39. [Molecular control of the cellular cycle and apoptosis: new treatments for gliomas].
Fueyo J; Gómez-Manzano C
Neurologia; 1998; 13(7):349-55. PubMed ID: 9810797
[TBL] [Abstract][Full Text] [Related]
40. [Brain tumors].
Hatano M; Mizuno M; Yoshida J
Gan To Kagaku Ryoho; 2003 Apr; 30(4):455-9. PubMed ID: 12722674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
